White Paper

On A Technology–Enabled Collision Course: Clinical Research And Clinical Practice Converge Through Real World Evidence

Source: ICON Plc
On A Technology–Enabled Collision Course: Clinical Research And Clinical Practice Converge Through Real World Evidence

Late Phase Research in the Life Sciences segment is undergoing a rapid transformation due to the digitalisation of healthcare and the greater availability of, and access to, Real World Data (RWD). This transformation is arriving not a moment too soon, given the changes anticipated from the Twenty-first Century Cures Act, EMA’s Adaptive Pathways approach, and the increased demand for Real World Evidence (RWE) generated from these RWD. In addition to supporting regulatory decisions, RWE is playing an ever expanding role in developing the product value propositions that are driving reimbursement decisions globally.